194 related articles for article (PubMed ID: 35020922)
1. Discriminative Capacity of CT Volumetry to Identify Autonomous Cortisol Secretion in Incidental Adrenal Adenomas.
Olmos R; Mertens N; Vaidya A; Uslar T; Fernandez P; Guarda FJ; Zúñiga Á; San Francisco I; Huete A; Baudrand R
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1946-e1953. PubMed ID: 35020922
[TBL] [Abstract][Full Text] [Related]
2. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
3. Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?
Araujo-Castro M; Robles Lázaro C; Parra Ramírez P; Cuesta Hernández M; Sampedro Núñez MA; Marazuela M
Endocrine; 2019 Dec; 66(3):650-659. PubMed ID: 31473918
[TBL] [Abstract][Full Text] [Related]
4. The association between adrenal adenoma size, autonomous cortisol secretion and metabolic derangements.
Bleier J; Pickovsky J; Apter S; Fishman B; Dotan Z; Tirosh A; Shlomai G
Clin Endocrinol (Oxf); 2022 Mar; 96(3):311-318. PubMed ID: 34877671
[TBL] [Abstract][Full Text] [Related]
5. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
Katabami T; Ishii S; Obi R; Asai S; Tanaka Y
Endocr J; 2016 Dec; 63(12):1123-1132. PubMed ID: 27616151
[TBL] [Abstract][Full Text] [Related]
6. Association between contralateral adrenal and hypothalamus-pituitary-adrenal axis in benign adrenocortical tumors.
Zhu H; Wu L; Su T; Jiang L; Zhou W; Jiang Y; Zhang C; Zhong X; Wang W
Front Endocrinol (Lausanne); 2023; 14():1199875. PubMed ID: 37560307
[TBL] [Abstract][Full Text] [Related]
7. Can Imaging Predict Subclinical Cortisol Secretion in Patients With Adrenal Adenomas? A CT Predictive Score.
Mosconi C; Vicennati V; Papadopoulos D; Dalmazi GD; Morselli-Labate AM; Golfieri R; Pasquali R
AJR Am J Roentgenol; 2017 Jul; 209(1):122-129. PubMed ID: 28402131
[TBL] [Abstract][Full Text] [Related]
8. Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
[TBL] [Abstract][Full Text] [Related]
9. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
Bardet S; Rohmer V; Murat A; Guillemot C; Maréchaud R; Chupin M; Lecomte P; Simon D; Delemer B; Schneebelli S; Beutter D; Jacquin V; Peltier P; Charbonnel B
Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
[TBL] [Abstract][Full Text] [Related]
10. Different patterns of steroid secretion in patients with adrenal incidentaloma.
Terzolo M; Osella G; Alì A; Borretta G; Magro GP; Termine A; Paccotti P; Angeli A
J Clin Endocrinol Metab; 1996 Feb; 81(2):740-4. PubMed ID: 8636297
[TBL] [Abstract][Full Text] [Related]
11. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
Tsagarakis S; Roboti C; Kokkoris P; Vasiliou V; Alevizaki C; Thalassinos N
Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
[TBL] [Abstract][Full Text] [Related]
12. Cortisol secretion from adrenal adenomas discovered as incidentalomas is responsive to ACTH.
Olsen H; Olofsson L; Mjöman M
Clin Endocrinol (Oxf); 2014 Mar; 80(3):335-41. PubMed ID: 23865937
[TBL] [Abstract][Full Text] [Related]
13. Attenuation Value in Adrenal Incidentalomas: A Longitudinal Study.
Ceccato F; Tizianel I; Voltan G; Maggetto G; Merante Boschin I; Quaia E; Crimì F; Scaroni C
Front Endocrinol (Lausanne); 2021; 12():794197. PubMed ID: 34925247
[TBL] [Abstract][Full Text] [Related]
14. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
Valli N; Catargi B; Ronci N; Vergnot V; Leccia F; Ferriere JM; Chene G; Grenier N; Laurent F; Tabarin A
Eur J Endocrinol; 2001 Apr; 144(4):401-8. PubMed ID: 11275951
[TBL] [Abstract][Full Text] [Related]
15. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma.
Fernández-Real JM; Engel WR; Simó R; Salinas I; Webb SM
Clin Endocrinol (Oxf); 1998 Jul; 49(1):53-61. PubMed ID: 9797847
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
[TBL] [Abstract][Full Text] [Related]
17. Role of computed tomography in predicting adrenal adenomas with cortisol hypersecretion.
Kim CK; Kang KA; Oh YL; Park SY
Br J Radiol; 2023 Sep; 96(1149):20221032. PubMed ID: 37393525
[TBL] [Abstract][Full Text] [Related]
18. Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden.
Olsen H; Nordenström E; Bergenfelz A; Nyman U; Valdemarsson S; Palmqvist E
Endocrine; 2012 Aug; 42(1):164-73. PubMed ID: 22350586
[TBL] [Abstract][Full Text] [Related]
19. The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk.
Di Dalmazi G; Fanelli F; Zavatta G; Ricci Bitti S; Mezzullo M; Repaci A; Pelusi C; Gambineri A; Altieri P; Mosconi C; Balacchi C; Golfieri R; Cosentino ER; Borghi C; Vicennati V; Pasquali R; Pagotto U
J Clin Endocrinol Metab; 2019 Nov; 104(11):5519-5528. PubMed ID: 31381072
[TBL] [Abstract][Full Text] [Related]
20. Is the 1mg-dexamethasone suppression test a precise marker of glucocorticoid excess and cardiometabolic risk in patients with adrenal incidentalomas?
Araujo-Castro M; Hanzu FA; Pascual-Corrales E; García Cano AM; Marchan M; Escobar-Morreale HF; Valderrabano P; Casals G
Endocrine; 2023 Oct; 82(1):161-170. PubMed ID: 37351760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]